Arrowhead Pharmaceuticals, Inc. Gains 40.33%

Wed 16 Sep 20 at 05:30 PM
Arrowhead Pharmaceuticals, Inc. Gains 40.33%

Arrowhead Pharmaceuticals, Inc. (ARWR:NASDAQ) rocketted at $47.43, a gain of 40.3%. The stock got featured on our News Catalysts scanner on Wed 16 Sep 20 at 01:11 PM in the 'MISCELLANEOUS' category. From Tue 01 Sep 20, the stock recorded 33.33% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Arrowhead Pharmaceuticals, Inc. (ARWR:NASDAQ)

Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.

Share